Eva Maria Fenyö (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eva Maria Fenyö" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

low place

low place

234^th place

397^th place

1lu.se

4,012^th place

4,295^th place

1fysiografen.se

low place

low place

fenyo.se (Global: low place; English: low place)

Fenyö EM. Intermezzo. Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, B3A:2 MTC News, No.56, 23-27, 2005.

fysiografen.se (Global: low place; English: low place)

Royal Physiographic Society of Lund Retrieved 2024-01-06

lu.se (Global: 4,012^th place; English: 4,295^th place)

lunduniversity.lu.se

Staff at Lund University Retrieved 2024-01-06.

nature.com (Global: 234^th place; English: 397^th place)

Berger EA, Doms RW, Fenyö EM et al.: A new classification for HIV-1. Nature 391:240, 1998.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Fenyö EM et al.: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 62:4414-4419, 1988.
Fenyö EM, Esbjörnsson J, Medstrand P, Jansson M. Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance. J Intern Med. 270:520-31, 2011.
Fenyö EM. Review: Antigenic variation of primate lentivirus in humans and experimentally infected macaques. Immunol Rev 140:131-46, 1994.
Albert J, Chiodi F, Fenyö EM. Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines. J Intern Med. 262:2-4, 2007.
Zhang Y-j et al.: Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis. Virology 197, 609-615, 1993.
Chiodi F, Fenyö EM. Neurotropism of human immunodeficiency virus. Brain Pathology 1:185-191, 1991.
Scarlatti, G et al.: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci, USA 90, 1721-1725, 1993.
Tscherning-Casper C et al.: The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol. 73:9673-9678, 1999.
Mörner A et al.: Primary HIV-2 isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol. 73:2343-2349, 1999.
Esbjörnsson J et al.: Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med. 367:224-32, 2012.

pmc.ncbi.nlm.nih.gov

Weber J, Fenyö EM et al.: Neutralisation serotypes of HIV-1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization. J Virol 70:7827-7832, 1996.